Ketan Bhupatrai Mehta - Net Worth and Insider Trading

Ketan Bhupatrai Mehta Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ketan Bhupatrai Mehta owns 1 companies in total, including Aytu BioPharma Inc (AYTU) .

Click here to see the complete history of Ketan Bhupatrai Mehta’s form 4 insider trades.

Insider Ownership Summary of Ketan Bhupatrai Mehta

Ticker	Comapny	Transaction Date	Type of Owner
AYTU	Aytu BioPharma Inc	2018-11-30	director

Ketan Bhupatrai Mehta Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ketan Bhupatrai Mehta Ownership Network

Ownership Network List of Ketan Bhupatrai Mehta

No Data

Ownership Network Relation of Ketan Bhupatrai Mehta

Ketan Bhupatrai Mehta Owned Company Details

What does Aytu BioPharma Inc do?

Who are the key executives at Aytu BioPharma Inc?

Ketan Bhupatrai Mehta is the director of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Financial Officer Mark K Oki , Chief Operating Officer Christopher Brooke , and Chief Business Officer Jarrett Disbrow .

Aytu BioPharma Inc (AYTU) Insider Trades Summary

Over the past 18 months, Ketan Bhupatrai Mehta made no insider transaction in Aytu BioPharma Inc (AYTU). Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 14,000 shares made by Joshua R. Disbrow ,

In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 14,000 shares were bought by its insiders, resulting in a net purchase of 14,000 shares.

Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aytu BioPharma Inc Insider Transactions

No Available Data

Ketan Bhupatrai Mehta Mailing Address

Above is the net worth, insider trading, and ownership report for Ketan Bhupatrai Mehta. You might contact Ketan Bhupatrai Mehta via mailing address: C/o Aytu Bioscience, Inc., 373 Inverness Parkway, Suite 206, Englewood Co 80112.

Discussions on Ketan Bhupatrai Mehta

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.